Legal & General Group
MRVI icon

Legal & General Group’s Maravai LifeSciences MRVI Stock Holding History

Legal & General Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.1K Hold
9,581
– – ﹤0.01% 2866
2025
Q4 		$31.1K Hold
9,581
– – ﹤0.01% 2858
2025
Q3 		$27.5K Sell
9,581
-1,568
-14% -$4K ﹤0.01% 2919
2025
Q2 		$26.9K Sell
11,149
-111,244
-91% -$234K ﹤0.01% 2889
2025
Q1 		$270K Hold
122,393
– – ﹤0.01% 2565
2024
Q4 		$667K Sell
122,393
-179
-0.1% -$1.15K ﹤0.01% 2365
2024
Q3 		$1.02M Buy
122,572
+333
+0.3% +$2.88K ﹤0.01% 2228
2024
Q2 		$875K Buy
122,239
+9,692
+9% +$83.7K ﹤0.01% 2238
2024
Q1 		$976K Sell
112,547
-516
-0.5% -$3.49K ﹤0.01% 2199
2023
Q4 		$741K Hold
113,063
– – ﹤0.01% 2310
2023
Q3 		$1.13M Buy
113,063
+5,260
+5% +$57.8K ﹤0.01% 2143
2023
Q2 		$1.34M Sell
107,803
-2,898
-3% -$39.1K ﹤0.01% 2092
2023
Q1 		$1.55M Buy
110,701
+7,304
+7% +$105K ﹤0.01% 1991
2022
Q4 		$1.48M Buy
103,397
+2,255
+2% +$35.5K ﹤0.01% 2007
2022
Q3 		$2.58M Sell
101,142
-4,849
-5% -$122K ﹤0.01% 1726
2022
Q2 		$3.01M Buy
105,991
+6,465
+6% +$205K ﹤0.01% 1675
2022
Q1 		$3.51M Buy
99,526
+611
+0.6% +$20.5K ﹤0.01% 1712
2021
Q4 		$4.14M Buy
98,915
+8,002
+9% +$324K ﹤0.01% 1675
2021
Q3 		$4.46M Buy
90,913
+42,957
+90% +$2.1M ﹤0.01% 1613
2021
Q2 		$2M Buy
47,956
+39,567
+472% +$1.53M ﹤0.01% 1973
2021
Q1 		$299K Sell
8,389
-10,653
-56% -$353K ﹤0.01% 2380
2020
Q4 		$533K Buy
+19,042
New +$530K ﹤0.01% 2247

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group's MRVI Position: Q1 2026 in Review

Legal & General Group held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 9,581 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2866.

Legal & General Group first reported a position in MRVI in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.46M in Q3 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Legal & General Group held 9,581 shares of Maravai LifeSciences worth $27.1K as of Q1 2026.
  • Legal & General Group left its Maravai LifeSciences share count unchanged in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2866 holding.
  • Legal & General Group first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 22 quarters since.
  • Legal & General Group's Maravai LifeSciences position peaked at $4.46M in Q3 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.